A further study reported upregulation in PD-L1 levels in CD133+CD44+ colorectal (CRC) cells and even higher in CD133+ CD44+ colorectal CSCs and CSC-enriched tumor spheres [79]. This evidence concerns the gene CD44 and neoplasm.